InsiderClue

Every filing, one decision per row.

Transactions

One row for every decision an insider filed. Open-market buying and selling only. Vesting, grants and the shares withheld to pay the tax on them are not decisions.

Views

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

Create an account Sign in
Companies 1/25
SKYE
Result 29 decisions over 120 months
Reset filters
Direction ?
Both29 Bought6 Sold23
Sort by ?
Most recent Largest amount Share of holding
Window ?
1 mo 12 mo 120 mo
Plan ?
Any Discretionary Scheduled (10b5-1) Not stated
Minimum amount ?
Any $100K $1M $10M $100M $500M
Share of their own holding ?
What the chief executive holds ?
Company: SKYE
Company
Date
Insider
Role
Action ?
Shares
Amount
Of holding
SKYE Skye Bioscience, Inc.
20 Aug 2026
5AM Partners VII, LLC
10% owner indirect
Sold at will 3×
7,700
$2.46K
12.2%
SKYE Skye Bioscience, Inc.
20 Aug 2026
Schwab Andrew J.
Director indirect
Sold at will 3×
7,700
$2.46K
12.2%
SKYE Skye Bioscience, Inc.
19 Aug 2026
5AM Partners VII, LLC
10% owner indirect
Sold at will 3×
68,140
$23.85K
55.2%
SKYE Skye Bioscience, Inc.
19 Aug 2026
Schwab Andrew J.
Director indirect
Sold at will 3×
68,140
$23.85K
55.2%
SKYE Skye Bioscience, Inc.
18 Aug 2026
5AM Partners VII, LLC
10% owner indirect
Sold at will 3×
300,000
$114.00K
84.3%
SKYE Skye Bioscience, Inc.
18 Aug 2026
Schwab Andrew J.
Director indirect
Sold at will 3×
300,000
$114.00K
84.3%
SKYE Skye Bioscience, Inc.
22 Aug 2025
5AM Partners VII, LLC
10% owner indirect
Sold at will 2×
170,449
$582.94K
74.8%
SKYE Skye Bioscience, Inc.
22 Aug 2025
Schwab Andrew J.
Director indirect
Sold at will 2×
170,449
$582.94K
74.8%
SKYE Skye Bioscience, Inc.
21 Aug 2025
5AM Partners VII, LLC
10% owner indirect
Sold at will 2×
60,956
$217.61K
48.8%
SKYE Skye Bioscience, Inc.
21 Aug 2025
Schwab Andrew J.
Director indirect
Sold at will 2×
60,956
$217.61K
48.8%
SKYE Skye Bioscience, Inc.
18 Nov 2024
Grayson Paul A.
Director
Sold at will
86,244
$430.36K
24.9%
SKYE Skye Bioscience, Inc.
18 Nov 2024
DHILLON PUNIT
Chief Executive Officer
Sold at will
82,546
$411.90K
20.0%
SKYE Skye Bioscience, Inc.
18 Nov 2024
ARSENAULT KAITLYN
Chief Financial Officer
Sold at will
43,206
$215.60K
20.6%
SKYE Skye Bioscience, Inc.
18 Nov 2024
Diep Tuan Tu
Chief Development Officer
Sold at will
19,489
$97.25K
19.2%
SKYE Skye Bioscience, Inc.
15 Nov 2024
DHILLON PUNIT
Chief Executive Officer
Sold at will
364
$2.02K
0.1%
SKYE Skye Bioscience, Inc.
15 Nov 2024
Grayson Paul A.
Director
Sold at will
307
$1.70K
0.1%
SKYE Skye Bioscience, Inc.
15 Nov 2024
ARSENAULT KAITLYN
Chief Financial Officer
Sold at will
190
$1.05K
0.1%
SKYE Skye Bioscience, Inc.
15 Nov 2024
Diep Tuan Tu
Chief Development Officer
Sold at will
85
$471.75
0.1%
SKYE Skye Bioscience, Inc.
13 Sep 2024
5AM Partners VII, LLC
10% owner indirect
Sold at will 3×
13,837
$83.85K
17.3%
SKYE Skye Bioscience, Inc.
13 Sep 2024
Schwab Andrew J.
Director indirect
Sold at will 3×
13,837
$83.85K
17.3%
SKYE Skye Bioscience, Inc.
11 Sep 2024
5AM Partners VII, LLC
10% owner indirect
Sold at will 3×
252,500
$1.67M
79.2%
SKYE Skye Bioscience, Inc.
11 Sep 2024
Schwab Andrew J.
Director indirect
Sold at will 3×
252,500
$1.67M
79.2%
SKYE Skye Bioscience, Inc.
13 Mar 2024
5AM Partners VII, LLC
10% owner indirect
Bought
450,000
$4.50M
5.7%
SKYE Skye Bioscience, Inc.
31 Jan 2024
5AM Partners VII, LLC
10% owner indirect
Bought
5,206,074
$12.03M
190%
SKYE Skye Bioscience, Inc.
29 Aug 2023
DHILLON PUNIT
Chief Executive Officer
Bought
881,000
$16.47K
2.2%
SKYE Skye Bioscience, Inc.
7 Aug 2020
DHILLON PUNIT
CEO
Bought
1,000,000
$100.00B
opened
SKYE Skye Bioscience, Inc.
7 Aug 2020
HEPPELL JAMES L
Director
Bought
500,000
$25.00B
opened
SKYE Skye Bioscience, Inc.
7 Aug 2020
Emerald Health Sciences Inc.
10% owner
Sold, plan not stated
3,000,000
$300.00K
2.4%
SKYE Skye Bioscience, Inc.
16 Feb 2018
Emerald Health Sciences Inc.
10% owner
Bought
15,000,000
no price
62.5%
Showing 1–29 of 29.